本页面由Tiger Trade Technology Pte. Ltd.提供服务

Recursion Pharmaceuticals, Inc.

2.84
-0.1000-3.40%
盘前2.840.0005+0.02%06:35 EDT
成交量:1,686.38万
成交额:4,809.72万
市值:14.98亿
市盈率:-1.97
高:2.94
开:2.93
低:2.80
收:2.94
52周最高:7.18
52周最低:2.80
股本:5.27亿
流通股本:4.15亿
量比:1.26
换手率:4.06%
股息:- -
股息率:- -
每股收益(TTM):-1.4410
每股收益(LYR):-1.4410
净资产收益率:-59.54%
总资产收益率:-27.72%
市净率:1.32
市盈率(LYR):-1.97

数据加载中...

2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report